跳至主要内容
临床试验/NL-OMON43959
NL-OMON43959招募中不适用

An exploratory pharmacokinetic and pharmacodynamic study of beta-lactam and fluoroquinolone in ICU patients - EXPAT

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • All the patients admitted to the ICU or internal medicine ward and given standard of care intravenous therapy of either one or both of the target antibiotic classes are included. Antibiotic initiation based on clinical suspicion of infection and/or cultured pathogens susceptible to the target drugs, initial dosage prescription, and duration of therapy are at the discretion of the attending physician. ;In order to be eligible to participate in this study, a subject must also meet all of the following criteria:
  • * Written informed consent has been obtained from the patient or their legally authorized representative.
  • * Receiving intravenous antibiotic therapy of the target drugs.
  • * Suitable intravenous/intra-arterial access to facilitate sample collection.
  • * Treatment should be aimed for at least at 3 days.
  • * Bacterial isolates sample are obtainable before start of the target drugs.

排除标准

  • * Consent not obtained.
  • * <18 years of age.
  • * Antibiotic cessation within 72h after start of the therapie.
  • * Medium care and burn wound patients admitted to the ICU.

研究者

相似试验

An exploratory pharmacokinetic and pharmacodynamic... | 临床试验